Oligosecretary Myeloma: Prevalence and Its Clinical Significance

S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.

NCT00919139 ·Status: COMPLETED

Carfilzomib, Lenalidomide, and Dexamethasone Re-induction Followed by the 2nd ASCT in Multiple Myeloma Patients Relapsed After the 1st ASCT

NCT05497102 ·Status: RECRUITING ·Phase: PHASE2

The Efficacy and Safety of Colchicine Combined With Conventional Therapy in Multiple Myeloma Patients

NCT05802992 ·Status: UNKNOWN ·Phase: PHASE3

Safety and Efficacy Study of GCS-100LE in the Treatment of Multiple Myeloma

NCT00609817 ·Status: TERMINATED ·Phase: PHASE1

Compare Clinical Outcomes Between Advanced Immunotherapy and Classical Immunochemotherapy in RRMM

NCT06205823 ·Status: ACTIVE_NOT_RECRUITING

A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple Myeloma

NCT00920556 ·Status: TERMINATED ·Phase: PHASE2

International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

NCT05669989 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Stem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple Myeloma

NCT01234129 ·Status: COMPLETED

Evaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to Establish New Recommendations.

NCT04144387 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

A Retreatment Study With Bortezomib for Multiple Myeloma

NCT01030302 ·Status: COMPLETED

A Phase IIa Study of Sotatercept on Bone Mass and Turnover in Patients With Multiple Myeloma

NCT02230917 ·Status: WITHDRAWN ·Phase: PHASE2

Familial Dysglobulinemia

NCT02853214 ·Status: COMPLETED ·Phase: NA

Trial of Bortezomib, Cytarabine, and Dexamethasone in Mantle Cell Lymphoma

NCT02840539 ·Status: COMPLETED ·Phase: PHASE2

Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma

NCT01861340 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Phase II Study of Carfilzomib, Pomalidomide, and Dexamethasone for Myeloma Patients Who Had Relapsed or Progressed After Carfilzomib, Lenalidomide, and Dexamethasone

NCT05509374 ·Status: UNKNOWN ·Phase: PHASE2

A Phase 2 Study of Lenalidomide to Evaluate the Efficacy in Japanese Patients With Newly Diagnosed Multiple Myeloma

NCT01698801 ·Status: COMPLETED ·Phase: PHASE2

Study to Demonstrate Clinical Benefit of Lenalidomide and Dexamethasone

NCT03809780 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Frontline Therapy in de Novo Multiple Myeloma Patients Under 65

NCT01206205 ·Status: COMPLETED ·Phase: PHASE2

A Registry Study of Participants With Multiple Myeloma in Latin America

NCT03955900 ·Status: COMPLETED

Daratumumab With DCEP for Multiple Myeloma With Plasmacytoma

NCT04065308 ·Status: UNKNOWN ·Phase: PHASE2

Microtransplantation Versus Auto-SCT in ≥PR Multiple Myeloma Patients

NCT02981199 ·Status: UNKNOWN ·Phase: NA

A Study to Investigate the Relationship Between Duration of Treatment and Response in Patients With Multiple Myeloma (MM) or Systemic AL Amyloidosis Treated in Real-life Practice

NCT04659798 ·Status: COMPLETED

Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma

NCT03127761 ·Status: RECRUITING

Consolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma

NCT00416208 ·Status: COMPLETED ·Phase: PHASE3

S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

NCT01055301 ·Status: WITHDRAWN ·Phase: PHASE2